tiprankstipranks
Soleno Therapeutics Announces Board Reshuffle and New Appointments
Company Announcements

Soleno Therapeutics Announces Board Reshuffle and New Appointments

Don't Miss Our Christmas Offers:

The latest announcement is out from Soleno Therapeutics (SLNO).

Soleno Therapeutics, Inc. announced that Dr. Ernest Mario, Chairman of the Board, is resigning due to health reasons, with no disagreements over the company’s operations. Matthew Pauls and Andrew Sinclair have been appointed to key leadership roles in the Board, with Dawn C. Bir joining as a new director. Bir brings valuable pharmaceutical experience, having held significant positions at Reata Pharmaceuticals and other notable companies. Her appointment includes a grant of restricted stock units as part of the company’s compensation policy for non-employee directors. The company’s recent board changes were publicized through a press release.

See more insights into SLNO stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlySoleno Therapeutics weakness a buying opportunity, says Baird
TheFlyShort Report: Bears look to fade Archer Aviation ascent
TheFlySoleno Therapeutics announces U.S.. FDA to ended review period for NDA
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App